Cambridge, MA, United States of America

Jianxin Chen

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 7.3

ph-index = 6

Forward Citations = 696(Granted Patents)


Location History:

  • Vancouver, CA (2010 - 2020)
  • Cambridge, MA (US) (2012 - 2024)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):

Title: Innovative Contributions of Inventor Jianxin Chen

Introduction: Jianxin Chen, an accomplished inventor based in Cambridge, MA, has made significant strides in the field of therapeutic delivery systems. With an impressive portfolio of 14 patents, his work focuses on developing innovative lipids and compositions that enhance the efficacy of drug delivery to cells.

Latest Patents: One of Chen's latest inventions, titled "Lipids and Compositions for the Delivery of Therapeutics," presents lipids that are designed for use in lipid particles intended for in vivo delivery of therapeutic agents. His formula details specific structures and components that include various alkyl and phosphor compounds aimed at optimizing the delivery system. This invention represents a step forward in how therapeutics are administered effectively, contributing to the evolving landscape of medical science.

Career Highlights: Throughout his career, Chen has held pivotal roles in prominent organizations such as Arbutus Biopharma Corporation and Tekmira Pharmaceuticals Corporation. His work in these companies has led to the development of cutting-edge technologies that directly address healthcare challenges, particularly in the field of biopharmaceuticals.

Collaborations: Jianxin Chen has collaborated with notable figures in the industry, including Kallanthottathil G Rajeev and Muthusamy Jayaraman. These partnerships have fostered a culture of innovation and have contributed to the advancement of research and development in therapeutic delivery mechanisms.

Conclusion: Jianxin Chen exemplifies the spirit of innovation through his continuous contributions to the field of therapeutic delivery systems. With his extensive patent portfolio and collaborative efforts, he remains a key figure in the advancement of effective healthcare solutions, influencing the future of medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…